Botulinum toxin use in neurology: Experience at Guillermo Almenara Irigoyen EsSalud Hospital
DOI:
https://doi.org/10.15381/anales.v65i3.1390Keywords:
Botulinum toxins, spasm, neuromuscular diseasesAbstract
Objective: To identify the utility, characteristics, outcome and adverse effects in the use of botulinum toxin in neurological disorders. Setting: EsSalud’s Guillermo Almenara National Hospital, Lima, Peru. Materials and Methods: One hundred and twenty-two patients received botulinum toxin type A in different neurological disorders. We determined the characteristics, outcome and adverse effects with the use of botulinum toxin. Results: The most frequent diagnosis was hemifacial spasm (63,1%), followed by spasticity (16,4%) and cervical dystonia (11,5%). The age of hemifacial spasm most frequent presentation was 60 to 69 year-old and in the left side. Torticollis and laterocollis were the most frequent types of cervical dystonia where botulinum toxin was used. There was good response in the treatment according to the favorable outcome by the TWSTRS scale performed before and 3 months posterior to treatment. The main reversible adverse effects were dry eye (15,6%), ecchymosis (9,1%) and pain at the site of application (7,8%). Conclusion: Botulinum toxin type A has many applications in neurological disorders, with good response and few adverse effects.Downloads
Published
2004-09-13
Issue
Section
Trabajos originales
License
Copyright (c) 2004 ÉDGARD ROJAS, CÉSAR CASTAÑEDA, ROBERTO PORTILLO, DAVID LIRA
![Creative Commons License](http://i.creativecommons.org/l/by-nc-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Those authors who have publications with this magazine accept the following terms:
- Authors will retain their copyrights and guarantee the journal the right of first publication of their work, which will be simultaneously subject to Creative Commons Attribution License that allows third parties to share the work as long as its author and its first publication this magazine are indicated.
- Authors may adopt other non-exclusive licensing agreements for the distribution of the version of the published work (eg, deposit it in an institutional electronic file or publish it in a monographic volume) provided that the initial publication in this magazine is indicated.
- Authors are allowed and recommended to disseminate their work over the Internet (eg: in institutional telematic archives or on their website) before and during the submission process, which It can produce interesting exchanges and increase quotes from the published work. (See El efecto del acceso abierto ).
How to Cite
1.
ROJAS ÉDGARD, CASTAÑEDA C, PORTILLO R, LIRA D. Botulinum toxin use in neurology: Experience at Guillermo Almenara Irigoyen EsSalud Hospital. An Fac med [Internet]. 2004 Sep. 13 [cited 2024 Jun. 30];65(3):188-93. Available from: https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/1390